Recurrent Intracerebral Hemorrhage: Associations with Comorbidities and Medicine with Antithrombotic Effects.
Intracerebral hemorrhage (ICH) is a disease with high mortality and a substantial risk of recurrence. However, the recurrence risk is poorly documented and the knowledge of potential predictors for recurrence among co-morbidities and medicine with antithrombotic effect is limited.1) To estimate the...
Main Authors: | Linnea Boegeskov Schmidt, Sanne Goertz, Jan Wohlfahrt, Mads Melbye, Tina Noergaard Munch |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5104445?pdf=render |
Similar Items
-
Recurrence of Subdural Haematoma in a Population-Based Cohort - Risks and Predictive Factors.
by: Linnea Schmidt, et al.
Published: (2015-01-01) -
Antithrombotic Treatment, Prehospital Blood Pressure, and Outcomes in Spontaneous Intracerebral Hemorrhage
by: Kristin Tveitan Larsen, et al.
Published: (2023-03-01) -
Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage
by: Michael Moussouttas
Published: (2012-01-01) -
Is the Benefit of Antithrombotics and Statins Worth the Risk of Intracerebral Hemorrhage?<subtitle>It Depends</subtitle>
by: Jose Gutierrez
Published: (2021-03-01) -
Disparities in brain health comorbidity management in intracerebral hemorrhage
by: Ernst Mayerhofer, et al.
Published: (2023-06-01)